Effects of Shockwave Therapy Versus Radiofrequency

Sponsor
Escola Superior de Tecnologia da Saúde do Porto (Other)
Overall Status
Completed
CT.gov ID
NCT04282057
Collaborator
(none)
30
1
3
3.9
7.7

Study Details

Study Description

Brief Summary

The main objective of this study is to compare the effect of 6 sessions of shock wave therapy versus radiofrequency followed by a protocol of moderate aerobic exercise, in the reduction of adiposity and abdominal flaccidity, in females between 18 and 60 years old. As a secondary objective, it is intended to understand the mechanism of fat mobilization by these two therapies.

Condition or Disease Intervention/Treatment Phase
  • Device: Radiofrequency
  • Device: Aerobic exercise
  • Device: Shock wave therapy
N/A

Detailed Description

With the increasing awareness of the population regarding the high rate of obesity and the number of deaths per year as a result of being overweight, treatments for reducing measures are increasingly sought.

The evidence shows that the accumulation of fat located in the abdominal region is a risk factor for dyslipidemia and arterial hypertension, and a reduction in waist circumference can reduce the potential risk of cardiovascular disease.

In addition to this concern, with the aging of the population and changes in body dimensions due to pregnancy or to a weight loss process, body flaccidity is also a growing cosmetic complaint, and the result is a less firm and pending skin.

Physical exercise is a very important agent for combating excess weight, with special attention to aerobic physical exercise, which is able to decrease body fat tissue and increase the oxidation of fatty acids by 5 to 10 times more than in resting state. The evidence points out that the exercise prescription to decrease fat mass should focus on a high volume of training (30 to 60 minutes) with moderate intensity (40 to 60% of Heart Rate Reserve), performed regularly and mobilizing large muscle groups.

In order to combat abdominal adiposity, as well as the flaccidity of the region, radiofrequency is presented as a possible complementary strategy.

Radiofrequency is an electromagnetic wave that when applied to skin, generates oscillating magnetic fields that move electrically charged particles producing heat in the tissues. The amount of heat produced is dependent on resistance.

Shock wave therapy consists of the application of high energy acoustic waves whose main characteristic is the production of a high pressure pulse induced in a short period of time. This will generate mechanical pressure waves in the tissues, promoting cavitation, with the formation of gas bubbles in the intervening fluids and an increase in local temperature.

The main objective of this study is to compare the effect of 6 sessions of shock wave therapy versus radiofrequency followed by a protocol of moderate aerobic exercise, in the reduction of adiposity and abdominal flaccidity, in females between 18 and 60 years old. As a secondary objective, it is intended to understand the mechanism of fat mobilization by these two therapies.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Care Provider, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effect of an Aerobic Exercise Program Associated With Shock Wave Therapy Versus Radiofrequency on Skin and Subcutaneous Tissue: Randomized Controlled Study
Actual Study Start Date :
Feb 22, 2020
Actual Primary Completion Date :
Apr 25, 2020
Actual Study Completion Date :
Jun 19, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: shockwave therapy group

This group performed aerobic exercise just after shock wave therapy in the abdominal region.

Device: Shock wave therapy
The shock wave device corresponds to the BTL-6000 X-Wave TM with a 20mm transmitter multifocal. The parameters used correspond to the pressure set between 2.8 and 3.5 bar, frequency 15 hertz and 3000 pulses per 10x15 cm area. It was used as a means contact gel for ultrasound, reference 033-051. In this procedure the participants found themselves in the supine position, with a pillow under the head and with the bending knees.

Experimental: radiofrequency group

This group performed aerobic exercise just after radiofrequency in the abdominal region.

Device: Radiofrequency
Radiofrequency protocol - The radiofrequency protocol was performed in dorsal decubitus, with the head elevated at 45 degrees. The application was in capacitive mode, with a 7cm electrode, always in movement. The duration of the application was established in 15 minutes, maintaining the local temperature between 40 to 42 celsius degrees at the epidermis.

Active Comparator: control group

This group only performed aerobic exercise.

Device: Aerobic exercise
Aerobic exercise protocol - 40 minutes of aerobic moderate-intensity exercise (45-55% of reserve heart rate) using Karvonen's formula, performed on a cycloergometer. The duration of the exercise was divided into three parts: warm-up (5 minutes); body (30 minutes); and cooling (from 5 to 10 minutes). The entire protocol was monitored through the Polar® brand heart rate monitor and watch.

Outcome Measures

Primary Outcome Measures

  1. Cutaneous abdominal tissue thickness [Baseline]

    Measurement of the cutaneous fold by ultrasonography

  2. Cutaneous abdominal tissue thickness [3 weeks after]

    Measurement of the cutaneous fold by ultrasonography

  3. Cutaneous abdominal tissue thickness [6 weeks after]

    Measurement of the cutaneous fold by ultrasonography

  4. Subcutaneous abdominal tissue thickness [Baseline]

    Measurement of the subcutaneous adipose fold by ultrasonography

  5. Subcutaneous abdominal tissue thickness [3 weeks after]

    Measurement of the subcutaneous adipose fold by ultrasonography

  6. Subcutaneous abdominal tissue thickness [6 weeks after]

    Measurement of the subcutaneous adipose fold by ultrasonography

  7. Glycerol concentration [Baseline]

    Blood analysis collection carried out with help from an clinical analysis technician

  8. Glycerol concentration [3 weeks after]

    Blood analysis collection carried out with help from an clinical analysis technician

  9. Glycerol concentration [6 weeks after]

    Blood analysis collection carried out with help from an clinical analysis technician

  10. Lipid profile (LDL, HDL and triglyceride concentrations) [Baseline]

    Blood analysis collection carried out with help from an clinical analysis technician

  11. Lipid profile (LDL, HDL and triglyceride concentrations) [3 weeks after]

    Blood analysis collection carried out with help from an clinical analysis technician

  12. Lipid profile (LDL, HDL and triglyceride concentrations) [6 weeks after]

    Blood analysis collection carried out with help from an clinical analysis technician

  13. Perimetry [Baseline]

    Perimetry consists of measuring circumferences. In this case, of the waist at the navel area, 3 cm below it and in the hip area

  14. Perimetry [3 weeks after]

    Perimetry consists of measuring circumferences. In this case, of the waist at the navel area, 3 cm below it and in the hip area

  15. Perimetry [6 weeks after]

    Perimetry consists of measuring circumferences. In this case, of the waist at the navel area, 3 cm below it and in the hip area

  16. Adipometry [Baseline]

    Adipometry consists of measuring skinfold thickness

  17. Adipometry [3 weeks after]

    Adipometry consists of measuring skinfold thickness

  18. Adipometry [6 weeks after]

    Adipometry consists of measuring skinfold thickness

  19. Inflammatory markers concentration (IL6, CRP, TNF) [Baseline]

    Blood analysis collection carried out with help from an clinical analysis technician

  20. Inflammatory markers concentration (IL6, CRP, TNF) [3 weeks after]

    Blood analysis collection carried out with help from an clinical analysis technician

  21. Inflammatory markers concentration (IL6, CRP, TNF) [6 weeks after]

    Blood analysis collection carried out with help from an clinical analysis technician

  22. Nitrous oxide concentration [Baseline]

    Blood analysis collection carried out with help from an clinical analysis technician

  23. Nitrous oxide concentration [3 weeks after]

    Blood analysis collection carried out with help from an clinical analysis technician

  24. Nitrous oxide concentration [6 weeks after]

    Blood analysis collection carried out with help from an clinical analysis technician

  25. Body composition- body mass [Baseline]

    body mass in kilograms

  26. Body composition- body mass [3 weeks after]

    body mass in kilograms

  27. Body composition- body mass [6 weeks after]

    body mass in kilograms

  28. Body composition- muscle mass [Baseline]

    muscle mass in kilograms

  29. Body composition- muscle mass [3 weeks after]

    muscle mass in kilograms

  30. Body composition- muscle mass [6 weeks after]

    muscle mass in kilograms

  31. Body composition- fat mass [Baseline]

    fat mass in kilograms

  32. Body composition- fat mass [3 weeks after]

    fat mass in kilograms

  33. Body composition- fat mass [6 weeks after]

    fat mass in kilograms

  34. Body composition- visceral fat [Baseline]

    visceral fat

  35. Body composition- visceral fat [3 weeks after]

    visceral fat

  36. Body composition- visceral fat [6 weeks after]

    visceral fat

  37. Body composition- fat body areas [Baseline]

    percentage of fat distributed by body areas

  38. Body composition- fat body areas [3 weeks after]

    percentage of fat distributed by body areas

  39. Body composition- fat body areas [6 weeks after]

    percentage of fat distributed by body areas

  40. Thermography [Baseline]

    Thermography is used to assess the temperature of the skin surface, and it is also possible to suppose changes in blood flow and vascularization with this outcome

  41. Thermography [3 weeks after]

    Thermography is used to assess the temperature of the skin surface, and it is also possible to suppose changes in blood flow and vascularization with this outcome

  42. Thermography [6 weeks after]

    Thermography is used to assess the temperature of the skin surface, and it is also possible to suppose changes in blood flow and vascularization with this outcome

  43. Photography [Baseline]

    Photography is used to compare the before and after images. With these it is possible to evaluate the skin flaccidity and fat

  44. Photography [3 weeks after]

    Photography is used to compare the before and after images. With these it is possible to evaluate the skin flaccidity and fat

  45. Photography [6 weeks after]

    Photography is used to compare the before and after images. With these it is possible to evaluate the skin flaccidity and fat

Secondary Outcome Measures

  1. skin flaccidity [Baseline]

    Investigator Assessment Skin Laxity Scoring System - Questionnaire that evaluates skin flaccidity and scores from 0 to 4. (As the subjectivity assessment of this outcome, the investigator who evaluates is blind to the group that the participants are allocated, in order to avoid partial scores)

  2. skin flaccidity [3 weeks after]

    Investigator Assessment Skin Laxity Scoring System - Questionnaire that evaluates skin flaccidity and scores from 0 to 4. (As the subjectivity assessment of this outcome, the investigator who evaluates is blind to the group that the participants are allocated, in order to avoid partial scores)

  3. skin flaccidity [6 weeks after]

    Investigator Assessment Skin Laxity Scoring System - Questionnaire that evaluates skin flaccidity and scores from 0 to 4. (As the subjectivity assessment of this outcome, the investigator who evaluates is blind to the group that the participants are allocated, in order to avoid partial scores)

  4. skin flaccidity and localized fat in the abdomen region [Baseline]

    Satisfaction questionnaire to evaluate the final results according to the participant

  5. skin flaccidity and localized fat in the abdomen region [3 weeks after]

    Satisfaction questionnaire to evaluate the final results according to the participant

  6. skin flaccidity and localized fat in the abdomen region [6 weeks after]

    Satisfaction questionnaire to evaluate the final results according to the participant

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Women aged 18 to 60 years
Exclusion Criteria:
  • smoking and drinking habits;

  • athletes;

  • people with dietary restrictions;

  • participants who have had diets to lose weight in the last 3 months or who will start during the study;

  • pregnant women;

  • in postpartum less than one year;

  • breastfeeding;

  • intending to become pregnant during the study period;

  • patients with electronic or metallic devices (pacemaker, IUD);

  • individuals with metabolic (including dyslipidemias);

  • hematological and renal disorders;

  • individuals with dermatological changes;

  • cardiovascular, respiratory, digestive, orthopedic, rheumatological and oncological pathologies;

  • changes in the immune system or with acute inflammatory processes;

  • changes in sensitivity or subject to medication (anti-coagulants, corticosteroids up to 6 weeks before, non-steroidal anti-inflammatory drugs, antihistamines, diuretics)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Andreia Noites Vila Nova de Gaia Porto Portugal 4400-330

Sponsors and Collaborators

  • Escola Superior de Tecnologia da Saúde do Porto

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Andreia Noites, Teacher, Escola Superior de Tecnologia da Saúde do Porto
ClinicalTrials.gov Identifier:
NCT04282057
Other Study ID Numbers:
  • AN-009
First Posted:
Feb 24, 2020
Last Update Posted:
Sep 30, 2020
Last Verified:
Sep 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Andreia Noites, Teacher, Escola Superior de Tecnologia da Saúde do Porto
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 30, 2020